Chondroitin 6-O-sulfotransferase requires PAPS for catalytic activity, and the abnormal PAPSS2 gene that encodes chondroitin 6-O-sulfotransferase can cause SEMD, Omani type [10]. Here, PAPSS2 is linked to spondyloepimetaphyseal dysplasia.